Alexandra Kogan
Overview
Explore the profile of Alexandra Kogan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
10
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fraterman I, Sacchi L, Mallo H, Tibollo V, Glaser S, Medlock S, et al.
JMIR Cancer
. 2025 Jan;
11:e58938.
PMID: 39883020
Background: Patients with melanoma receiving immunotherapy with immune-checkpoint inhibitors often experience immune-related adverse events, cancer-related fatigue, and emotional distress, affecting health-related quality of life (HRQoL) and clinical outcome to immunotherapy....
2.
ATC-to-RxNorm mappings - A comparison between OHDSI Standardized Vocabularies and UMLS Metathesaurus
de Groot R, Glaser S, Kogan A, Medlock S, Alloni A, Gabetta M, et al.
Int J Med Inform
. 2025 Jan;
195:105777.
PMID: 39753061
Introduction: The World Health Organization global standard for representing drug data is the Anatomical Therapeutic Chemical (ATC) classification. However, it does not represent ingredients and other drug properties required by...
3.
Fraterman I, Wollersheim B, Tibollo V, Glaser S, Medlock S, Cornet R, et al.
JMIR Res Protoc
. 2023 Oct;
12:e49252.
PMID: 37819691
Background: Since treatment with immune checkpoint inhibitors (ICIs) is becoming standard therapy for patients with high-risk and advanced melanoma, an increasing number of patients experience treatment-related adverse events such as...
4.
Lanzola G, Polce F, Parimbelli E, Gabetta M, Cornet R, de Groot R, et al.
Appl Clin Inform
. 2023 Jun;
14(4):725-734.
PMID: 37339683
Background: Within the CAPABLE project the authors developed a multi-agent system that relies on a distributed architecture. The system provides cancer patients with coaching advice and supports their clinicians with...
5.
Van Woensel W, Tu S, Michalowski W, Abidi S, Abidi S, Alonso J, et al.
J Biomed Inform
. 2023 May;
142:104395.
PMID: 37201618
Objective: The study has dual objectives. Our first objective (1) is to develop a community-of-practice-based evaluation methodology for knowledge-intensive computational methods. We target a whitebox analysis of the computational methods...
6.
OSullivan D, Van Woensel W, Wilk S, Tu S, Michalowski W, Abidi S, et al.
AMIA Annu Symp Proc
. 2022 Mar;
2021:920-929.
PMID: 35308994
Multimorbidity, the coexistence of two or more health conditions, has become more prevalent as mortality rates in many countries have declined and their populations have aged. Multimorbidity presents significant difficulties...
7.
The Case Manager: Driving Medical Reasoning in a Distributed Environment for Home Patient Monitoring
Polce F, Lanzola G, Gabetta M, Parimbelli E, Wilk S, Glasspool D, et al.
Stud Health Technol Inform
. 2021 May;
281:610-614.
PMID: 34042648
The CAPABLE project has been funded by the EU Horizon 2020 Programme over the years 2020-24 to support home care. A system is being designed and implemented supporting remote monitoring...
8.
Kogan A, Peleg M, Tu S, Allon R, Khaitov N, Hochberg I
J Biomed Inform
. 2020 Oct;
112:103587.
PMID: 33035704
Patients with chronic multimorbidity are becoming more common as life expectancy increases, making it necessary for physicians to develop complex management plans. We are looking at the patient management process...
9.
Kogan A, Tu S, Peleg M
AMIA Annu Symp Proc
. 2019 Mar;
2018:690-699.
PMID: 30815111
Computer-interpretable guidelines (CIGs) are based on clinical practice guidelines, which typically address a single morbidity. However, most of the aging population suffers from multiple morbidities. Currently, there is no demonstrated...